GlassScriptPhysician profile
James L Edwards
NPI 1972684231
$1,074.04
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $296 · 2021: $33.26.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $248.30 | 2019-2021 | |
| Janssen Biotech, INC. | $202.57 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $114.97 | 2019 | |
| Pfizer INC. | $106.90 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.31 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.17 | 2019 | |
| Redhill Biopharma INC. | $47.02 | 2020 | |
| Ucb, INC. | $46.71 | 2019 | |
| Shionogi INC | $44.65 | 2019 | |
| Intercept Pharmaceuticals, INC. | $38.04 | 2019-2020 | |
| Gilead Sciences, INC. | $26.92 | 2019 | |
| Shire North American Group INC | $24.88 | 2019 | |
| Ironwood Pharmaceuticals, INC | $24.79 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $11.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.